NMD Pharma initiates Phase II trial of NMD670 in Spinal Muscular Atrophy
Aarhus, Denmark, 26 September 2023– NMD Pharma A/S, a clinical-stage biotech company developing first-in-class, small molecule ClC-1 inhibitors directly targeting muscle function within neuromuscular disorders, today announces that the first... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - September 26, 2023 Category: Pharmaceuticals Source Type: clinical trials

Chronic Venous Insufficiency and Balneotherapy
Conditions: Chronic Venous Insufficiency; Chronic Venous Disease Interventions: Procedure: SPA THERAPY Sponsors: CEN Biotech; TOWN HALL OF ROYAT Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 26, 2023 Category: Research Source Type: clinical trials

A Phase III Clinical Trial of Quadrivalent Influenza Vaccine in Healthy Subjects Aged 6 to 35 Months
Condition:   Seasonal Influenza Interventions:   Biological: Quadrivalent influenza vaccine(0.25ml);   Biological: Quadrivalent influenza vaccine(0.5ml);   Biological: Trivalent influenza vaccine(BV);   Biological: Trivalent influenza vaccine(BY) Sponsor:   Sinovac Biotech Co., Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2023 Category: Research Source Type: clinical trials

A Trial to Evaluate the Safety, Tolerability, and Efficacy of NCR100 Injection in the Treatment of Subjects With KOA
Condition:   Knee Osteoarthritis Intervention:   Biological: NCR100 injection Sponsors:   Nuwacell Biotechnologies Co., Ltd.;   Shanghai 6th People's Hospital;   Beijing Luhe Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2023 Category: Research Source Type: clinical trials

Relationship Between Individual Effect of Diet on Postprandial Glycemia and Gut Microbiome Profile in Healthy Subjects
Conditions:   Glucose Metabolism Disorders;   Health Behavior;   Diabetes;   Metabolic Disease Interventions:   Other: Standardized breakfast A;   Other: Standardized breakfast B Sponsor:   BiomeHub Biotechnology Company Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2023 Category: Research Source Type: clinical trials